Roberta Lemay

2.1k total citations
17 papers, 1.5k citations indexed

About

Roberta Lemay is a scholar working on Physiology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Roberta Lemay has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 8 papers in Organic Chemistry and 6 papers in Epidemiology. Recurrent topics in Roberta Lemay's work include Lysosomal Storage Disorders Research (15 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Glycogen Storage Diseases and Myoclonus (5 papers). Roberta Lemay is often cited by papers focused on Lysosomal Storage Disorders Research (15 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Glycogen Storage Diseases and Myoclonus (5 papers). Roberta Lemay collaborates with scholars based in United States, France and United Kingdom. Roberta Lemay's co-authors include Stephen Waldek, Maryam Banikazemi, Dominique P. Germain, William R. Wilcox, Philip Lee, David G. Warnock, Robert J. Hopkin, Manesh R. Patel, Christine M. Eng and Alberto Ortíz and has published in prestigious journals such as Clinical Journal of the American Society of Nephrology, Nephrology Dialysis Transplantation and Journal of Medical Genetics.

In The Last Decade

Roberta Lemay

15 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Lemay United States 11 1.4k 628 469 411 341 17 1.5k
Renzo Mignani Italy 19 1.0k 0.7× 381 0.6× 365 0.8× 276 0.7× 270 0.8× 58 1.3k
Juan Politei Argentina 19 1.6k 1.1× 606 1.0× 580 1.2× 405 1.0× 394 1.2× 80 1.9k
Anouk C. Vedder Netherlands 12 1.5k 1.1× 728 1.2× 411 0.9× 441 1.1× 445 1.3× 16 1.6k
Marieke Biegstraaten Netherlands 17 1.1k 0.8× 410 0.7× 290 0.6× 316 0.8× 386 1.1× 29 1.3k
Dawn A. Laney United States 13 871 0.6× 374 0.6× 316 0.7× 233 0.6× 220 0.6× 43 1.0k
F. Dehout Belgium 7 926 0.6× 449 0.7× 346 0.7× 239 0.6× 239 0.7× 13 1.0k
Elke Miebach Germany 13 989 0.7× 521 0.8× 291 0.6× 181 0.4× 173 0.5× 15 1.1k
Severo Pagliardini Italy 11 795 0.6× 373 0.6× 263 0.6× 267 0.6× 216 0.6× 14 988
Helena Poupětová Czechia 17 932 0.7× 407 0.6× 207 0.4× 196 0.5× 272 0.8× 40 1.1k
Daniel Oder Germany 12 748 0.5× 351 0.6× 179 0.4× 232 0.6× 246 0.7× 26 828

Countries citing papers authored by Roberta Lemay

Since Specialization
Citations

This map shows the geographic impact of Roberta Lemay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Lemay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Lemay more than expected).

Fields of papers citing papers by Roberta Lemay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Lemay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Lemay. The network helps show where Roberta Lemay may publish in the future.

Co-authorship network of co-authors of Roberta Lemay

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Lemay. A scholar is included among the top collaborators of Roberta Lemay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Lemay. Roberta Lemay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Blanchet, Pascal, et al.. (2025). Prostate cancer as an occupational disease: the actual impact in a high-incidence area. PubMed. 35(9). 102933–102933.
2.
Lao, Patrick J., Natalie Edwards, Lisi Flores Aguilar, et al.. (2025). Longitudinal changes in white matter hyperintensity volume accelerate across the Alzheimer's continuum in adults with Down syndrome. Alzheimer s & Dementia. 21(9). e70679–e70679.
3.
Germain, Dominique P., João Paulo Oliveira, Daniel G. Bichet, et al.. (2020). Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: a consensus classification system by a multispecialty Fabry disease genotype–phenotype workgroup. Journal of Medical Genetics. 57(8). 542–551. 51 indexed citations
4.
Hopkin, Robert J., Dominique P. Germain, Daniel G. Bichet, et al.. (2018). A survivor analysis for major clinical events in heterozygous female patients with Fabry disease using group consensus phenotype classifications from hemizygous male patients. Molecular Genetics and Metabolism. 123(2). S65–S66. 1 indexed citations
5.
Wilcox, William R., Ulla Feldt‐Rasmussen, Ana María Martins, et al.. (2017). Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry. JIMD Reports. 38. 45–51. 25 indexed citations
6.
Hopkin, Robert J., Gustavo Cabrera, Joel Charrow, et al.. (2016). Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry. Molecular Genetics and Metabolism. 119(1-2). 151–159. 41 indexed citations
7.
Germain, Dominique P., Joel Charrow, Robert J. Desnick, et al.. (2015). Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. Journal of Medical Genetics. 52(5). 353–358. 253 indexed citations
8.
Hopkin, Robert J., et al.. (2013). Early initiation of agalsidase beta treatment is associated with fewer clinical events in women with Fabry disease: Data from the Fabry Registry. Molecular Genetics and Metabolism. 108(2). S49–S49. 1 indexed citations
9.
Villalobos, Jacobo, Juan Politei, Ana María Martins, et al.. (2012). Fabry Disease in Latin America: Data from the Fabry Registry. JIMD Reports. 8. 91–99. 13 indexed citations
10.
Hopkin, Robert J., Michael Mauer, Roberta Lemay, Jörg Strotmann, & Katherine B. Sims. (2012). Fabry Registry Data Indicate that Early Initiation of Agalsidase Beta Treatment is Associated with Fewer Clinical Events. Molecular Genetics and Metabolism. 105(2). S36–S36. 1 indexed citations
11.
Warnock, David G., Alberto Ortíz, Michael Mauer, et al.. (2011). Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrology Dialysis Transplantation. 27(3). 1042–1049. 123 indexed citations
12.
Banikazemi, Maryam, Manesh R. Patel, Roberta Lemay, & Stephen Waldek. (2010). 10. Life expectancy and cause of death in Fabry disease: Findings from the Fabry Registry. Molecular Genetics and Metabolism. 99(2). S10–S10. 1 indexed citations
13.
Wanner, Christoph, João Paulo Oliveira, Alberto Ortíz, et al.. (2010). Prognostic Indicators of Renal Disease Progression in Adults with Fabry Disease. Clinical Journal of the American Society of Nephrology. 5(12). 2220–2228. 106 indexed citations
14.
Kishnani, Priya S., M. DiRocco, Paige Kaplan, et al.. (2009). A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. Molecular Genetics and Metabolism. 96(4). 164–170. 30 indexed citations
15.
Waldek, Stephen, Manesh R. Patel, Maryam Banikazemi, Roberta Lemay, & Philip Lee. (2009). Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry. Genetics in Medicine. 11(11). 790–796. 248 indexed citations
16.
Hopkin, Robert J., John J. Bissler, Maryam Banikazemi, et al.. (2008). Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry. Pediatric Research. 64(5). 550–555. 216 indexed citations
17.
Wilcox, William R., João Paulo Oliveira, Robert J. Hopkin, et al.. (2007). Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry. Molecular Genetics and Metabolism. 93(2). 112–128. 390 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renzo Mignani Breakdown of academic impact, for papers by Juan Politei Breakdown of academic impact, for papers by Anouk C. Vedder Breakdown of academic impact, for papers by Marieke Biegstraaten Breakdown of academic impact, for papers by Dawn A. Laney Breakdown of academic impact, for papers by F. Dehout Breakdown of academic impact, for papers by Elke Miebach Breakdown of academic impact, for papers by Severo Pagliardini Breakdown of academic impact, for papers by Helena Poupětová Breakdown of academic impact, for papers by Daniel Oder
Rankless by CCL
2026